At ILSI, we bring science and research to diverse audiences through a wide range of events. From independent symposia and workshops to hands-on training sessions, we host, sponsor, and co-organize events that foster learning and collaboration. Many of ILSI's events are also featured as part of larger scientific and professional conferences, further expanding opportunities for engagement, dialogue, and discovery. Join us!
2026
Workshop – Shaping Metabolic Health: GLP-1 Receptor Agonists, Prebiotics, and the Gut–Brain Axis
2026-03-04 – 2026-03-05
Brussels, Belgium
This workshop will convene leading researchers and clinicians to review the current evidence, define research priorities, and explore translational pathways at the intersection of GLP-1 biology, prebiotics, the gut–brain axis, and metabolic and cognitive health. The programme combines expert talks, panel discussions, and interactive group formats (a World Café).
Workshop – Nutritional Interventions for Healthy Ageing
2026-02-16 – 2026-02-17
Brussels, Belgium
Workshop organised by the ILSiEurope Healthy Ageing Task Force to identify research and translation gaps in nutritional strategies for healthy ageing.
Asamblea General Ordinaria ILSI Mesoamérica 2026
2026-02-12
San José, Costa Rica
Symposium on Enhancing the Design of Nutrient Clinical Trials for Disease Prevention: A Focus on Vitamin D and Health Outcomes
2026-02-10
30 Medical Drive, Singapore
ILSI Southeast Asia Region, Institute for Human Development and Potential (IHDP), A*STAR, Singapore, and Human Potential Translational Research Programme (HPTRP), Yong Loo Lin School of Medicine, National University of Singapore, are organizing a symposium to share key insights on improving nutrient clinical trial design for disease prevention, focusing on vitamin D and related health outcomes.
Vitamin D and Cardiovascular Disease: What is the Latest Science?
2026-02-09
11 Mandalay Road, Singapore 308232
ILSI Southeast Asia Region and the Department of Metabolism, Nutrition and Health, Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore are hosting a guest lecture by Prof. Dr. Sunil Wimalawansa to share the latest insights on vitamin D and CVD, and its implications in Asia.
- 10:45 - Prof. Gary Frost, Imperial College London - Understanding the relationship between Prebiotics, gastrointestinal environment and GLP-1 release and physiology
- 11:15 - Prof. Patrice Cani, UCLouvain - Targeting the gut microbiota with prebiotics to modulate endogenous GLP-1: from bench to bedside
- 11:45 - Dr. Harriet Schellekens, University College Cork - Beyond GLP-1 Agonists: Microbiota-Driven Modulation of Satiety and Metabolic Health Across the Lifespan
12:15 - Lunch
Session 2 - From Gut to Brain: Nutritional Modulation of Cognition, Mood, and Eating Behavior
This session explores how nutrition and gut-brain signaling shape cognition, mood, and eating behavior. It will examine both the lived experience of drug treatment and the emerging cognitive and mental health effects of GLP-1-based therapies, moving beyond weight loss to consider broader psychological outcomes.
- 13:20 - Dr. Francesca Cirulli, Prof. Suzanne Dickson (ECNP) - ECNP Network presentation
- 13:30 - Prof. Lora Heisler (University of Aberdeen) -Effect of GLP-1R agonists on consummatory behaviour in mice
- 14:00 - Prof. Kieran Tuohy (University of Leeds) - GLP-RA and the Gut Microbiome - Keeping a Good Thing Going
- 14:30 -Prof. Riccardo De Giorgi, (University of Oxford) - Promises & pitfalls of GLP-1RAs in cognitive and mental disorders: evidence and perspectives
15:00 - Coffee Break
15:30 - World Café Discussion: participants rotate between themed tables to discuss emerging topics, key challenges, and the next steps of the future of metabolic health.
17:00 - Wrap-up and Day 1 Reflections17:15 - Networking Drink
Day 2
9:00 - Welcome to Day 2 & Recap of Day 1
Session 3 - GLP-1 Innovation in Clinical Reality
This session will spotlight how GLP-1-based therapies are reshaping day-to-day clinical practice. The discussion will revolve around real-world use, including benefits, risks, and practical challenges such as access, adherence, and long-term management. The session will offer an up-to-date view of "what's really happening" with GLP-1 in clinics and with patients.
- 9:10 - Prof Giles Yeo (Wolfson College) - University of Cambridge - In a world of GLP1 therapies, have we cured obesity?
- 9:50 - Kelly Dowson (F!S Group) - From Prescription to Reality: What Consumers Really Experience on GLP-1 Medication
10:30 - Coffee break
11:00 - Debrief: Key Points Emerging from the World Café Discussions12:30 - Closing: Summary and Future Outlook
12:45 - End of the workshop
Registration
Register hereFees
- Industry Experts (part of ILSI Europe): free access
- Industry Experts (not part of ILSI Europe): 350€
- Academic Experts (part of ILSI Europe): free access
- Academic Experts (not part of ILSI Europe): 175€
- Public Sector Experts (part of ILSI Europe): free access
- Public Sector Experts (not part of ILSI Europe): 175€
- Students: 75€
Venue
The workshop will take place at the ILSI Europe Office, Avenue E. Mounier 83, Box 6, B-1200 Brussels, Belgium
Find more info on how to reach us here.
Accomodation
Participants are invited to stay at ROXI The Urban Residence Brussels, conveniently located just a 6-minute walk from ILSI Europe (Hippokrateslaan 14, 1932 Zaventem).
The residence offers comfortable, modern accommodation at competitive rates ranging from €77 to €149 per night (plus city tax).
For bookings and enquiries: +32 (0) 2 669 29 70 | brussels@roxi-residence.com | https://roxi-residence.com/.
Organising Commitee
Co-organised by the ILSI Europe Prebiotics Task Force and the Nutrition for the Ageing Brain Symposium Committee
- Georgia Chatonidi - Örebro University
- Lars Christensen - Arla
- Louise Dye - University of Sheffield
- Robert Steinert - DSM
- Clémentine Thabuis - Roquette
- Sandrine Thuret - King's College London
- Maria Tonti - ILSI Europe
- Wim Vandenberghe - University of Antwerp
- David Vauzour - University of East Anglia
- Jessica Van Harsselaar - Beneo
- Elaine Vaughan - Sensus
The ILSI Europe Healthy Europe Task Force is organising an expert workshop to identify research and translation gaps in nutritional strategies to support healthy ageing. The outcome of this workshop will inform the Task Force's agenda and the direction of future research activities on nutritional interventions to be developped in 2026. These activities could potentially include: Determining factors that impact our immune system and link them to specific ingredients, foods or diets; and: Pinpointing ingredients, foods, and/or diets that support healthy ageing.
Workshop Objectives and Background
The workshop "Nutritional Interventions for Healthy Ageing: Research Gaps and Future Directions" will explore the current state of science in nutritional approaches to support healthy ageing, with the goal of identifying key research and translation gaps. The agenda will focus on critical themes including the gut microbiome, cognition, muscle health, mitochondrial fitness, and sustainable diets, all within the context of age-specific diet efficacy and nutritional strategies across the lifespan. In addition to mapping existing evidence, the workshop will address challenges in defining appropriate clinical endpoints and designing effective interventions tailored to different stages of ageing.
Featuring three keynote presentations and a series of interactive sessions, including panel discussions, the workshop will encourage interdisciplinary dialogue to shape future research priorities, support the development of targeted nutritional interventions, and lay the groundwork for collaborative clinical research in the field of healthy ageing.
This activity will result in peer-reviewed proceedings and actionable insights to guide future research in nutritional interventions in healthy ageing.
Read the proceedings of our previous workshop here: Building a roadmap to nutrition for Healthy Ageing: a brief report on the ILSI Europe Healthy Agein…
Workshop Agenda
Day 1
10:00 - Registration & Welcome Coffee
10:30 - ILSI Europe Presentation10:40 - Healthy Ageing Task Force Introduction and Aim of the Workshop
10:50 - Prof. Matteo Cesari (World Health Organisation), Advancing Healthy Ageing Through Nutrition
11:20 - Prof. Anne-Marie Minihane (University of East Anglia) - Early Nutrition Intervention to Promote Healthy Life Expectancy
11:50 - Coffee Break
12:20 - Dr. Miguel Gueimonde (CSIC) - Nutrition for Healthy Ageing Through the Gut Microbiota lens12:50 - Prof. Piril Hepsomali (University of Reading) - Nutrition and Cognition in Aging: Evidence, Challenges, and Opportunities
13:20 - Lunch
14:30 - Prof. Pol Grootswagers (Wageningen University) - Nutritional Interventions to Slow Muscle Ageing15:00 - Dr. Asya Dolgikh (EPFL) - Precision Nutrition for Mitochondrial Health: From Accelerated Disease Models to Healthy Aging
15:30 - Coffee Break
15:50 - Evidence and Gaps Wall16:50 - Closing Day 1 and Setting the Stage for Day 2
19:00 - Dinner
Day 2
9:00 - Welcome Coffee
9:30 - Start of Day 2: Introduction to World Café9:40 - World Café: Co-Creating Research Directions
11:00 - Coffee Break
11:30 - Dissemination of Discussions Conclusions12:30 - Workshop Closing: What's Next
13:00 - Lunch
Organising Committee
- Miguel Gueimonde, Instituto de Productos Lácteos de Asturias, ES
- Pol Grootswagers, Wageningen University & Research, NL
- Piril Hepsomall, University or Reading, UK
- Bruno Pot, Yakult Europe, NL
- Rachael Patusco, Haleon, US
- Maria Tonti, ILSI Europe, BE
Registration
This workshop is upon invitation only. Invited experts can register via the registration form sent by email.
If you're interested in this topic and believe you can bring a valuable contribution to the discussion, please contact mtonti@ilsieurope.be.
Organised by the Healthy Ageing Task Force.
[post_title] => Workshop - Nutritional Interventions for Healthy Ageing [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => workshop-nutritional-interventions-for-healthy-ageing [to_ping] => [pinged] => [post_modified] => 2026-02-12 06:59:42 [post_modified_gmt] => 2026-02-12 11:59:42 [post_content_filtered] => [post_parent] => 0 [guid] => https://ilsi.org/?post_type=event&p=52163 [menu_order] => 0 [post_type] => event [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 52304 [post_author] => 37 [post_date] => 2026-02-16 20:24:25 [post_date_gmt] => 2026-02-16 20:24:25 [post_content] =>Como todos los años y siguiendo los estatutos que nos rigen, ILSI Mesoamérica lleva a cabo su Asamblea General Ordinaria correspondiente al año 2026, en la cual se hace una revisión de los objetivos logrados durante el año 2025 y las actividades que se llevarán a cabo en el 2026.
Para esta ocasión especial se contará con la participación de representantes de todos los miembros industriales, así como los representantes de los miembros académicos. La Asamblea se llevará a cabo de manera online por medio de la plataforma GotoMeeting.
Para conocer la agenda de la asamblea, puede hacerlo aquí.
Informes presentados:
- El Sr. José Vega Baudrit, presidente de ILSI Mesoamérica, presenta el informe de labores de 2025
- La Sra. Carmela Velázquez, tesorera de ILSI Mesoamérica presenta los estados financieros 2025
- La Dra. Hannia León, directora ejecutiva de ILSI Mesoamérica, presenta el Plan de trabajo y Programa científico 2026
- La Sra. Gabriela Ortiz, Fiscal de ILSI Mesoamérica, presenta el informe de Fiscalía 2025
[post_title] => Asamblea General Ordinaria ILSI Mesoamérica 2026 [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => asamblea-general-ordinaria-ilsi-mesoamerica-2026 [to_ping] => [pinged] => [post_modified] => 2026-02-16 15:33:12 [post_modified_gmt] => 2026-02-16 20:33:12 [post_content_filtered] => [post_parent] => 0 [guid] => https://ilsi.org/?post_type=event&p=52304 [menu_order] => 0 [post_type] => event [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 52272 [post_author] => 353 [post_date] => 2026-01-12 00:53:02 [post_date_gmt] => 2026-01-12 05:53:02 [post_content] =>
BACKGROUND
Obesity, osteoporosis and sarcopenia present enormous global health and economic challenges, which are exacerbated in aging populations. Singapore is one of the countries with the highest prevalence of osteoporotic hip fractures in the world. A recent study in Singapore has studied complex relationships between fat mass (FM), lean mass (LM), and bone mass, with significant implications for obesity, frailty, and bone fractures later in life.
Vitamin D is essential for bone health, but also for many roles beyond the musculoskeletal system, including the immune, pulmonary, and cardiovascular systems; pregnancy; autoimmune disorders; and cancer. However, inappropriate or flawed study designs have been frequently found in clinical trials, which led to misleading interpretations.
Evidence from adequately powered epidemiological studies and RCTs in vitamin D-deficient populations shows favorable clinical outcomes, enriching the literature and improves understanding of its physiology and mechanisms. Proper study designs with rigorous methodologies and cautious interpretation of outcomes are crucial, and these principles are equally relevant to other micronutrients and nutrient/nutraceutical research, enhancing the credibility of clinical trials, systematic reviews, and meta-analyses.
ILSI Southeast Asia Region, Institute for Human Development and Potential (IHDP), A*STAR, Singapore, and Human Potential Translational Research Programme (HPTRP), Yong Loo Lin School of Medicine, National University of Singapore are organizing a symposium to share key insights on improving nutrient clinical trial design for disease prevention, focusing on vitamin D and related health outcomes.
SPEAKERS
REGISTRATION
This symposium offers complimentary registration. Due to limited seating, early registration is highly encouraged. Register now by clicking the button below:
Register HereORGANIZERS
CONTACT
If you have any inquiries, please do not hesitate to contact the following:
[post_title] => Symposium on Enhancing the Design of Nutrient Clinical Trials for Disease Prevention: A Focus on Vitamin D and Health Outcomes [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => vit-d-symposium-2026 [to_ping] => [pinged] => [post_modified] => 2026-01-21 21:53:43 [post_modified_gmt] => 2026-01-22 02:53:43 [post_content_filtered] => [post_parent] => 0 [guid] => https://ilsi.org/?post_type=event&p=52272 [menu_order] => 0 [post_type] => event [post_mime_type] => [comment_count] => 0 [filter] => raw ) [4] => WP_Post Object ( [ID] => 52284 [post_author] => 353 [post_date] => 2026-01-22 10:58:52 [post_date_gmt] => 2026-01-22 10:58:52 [post_content] =>The role of vitamin D in reducing cardiovascular disease (CVD) risk remains debated despite growing evidence, with observational studies consistently linking low serum vitamin D levels with higher CVD risk. Its role in modulating inflammation and oxidative stress, improving endothelial function, and reducing cardiometabolic risk factors supports a comprehensive, multi-modal approach to cardiovascular health. In Singapore, 30-50% of the population, with prevalence higher in Malay ethnic groups, indoor workers etc., remains vitamin D deficient or insufficient despite year-round sunshine.
ILSI Southeast Asia Region and the Department of Metabolism, Nutrition and Health, Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore are hosting a guest lecture by Prof. Dr. Sunil Wimalawansa to share the latest insights on vitamin D and CVD, and its implications in Asia.
ABOUT THE SPEAKER
Prof Dr Sunil J. Wimalawansa
Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof Dr Sunil Wimalawansa is a globally renowned expert in endocrinology, osteoporosis and metabolic bone diseases, as well as nutrition and vitamin D. A clinician-scientist with more than three decades of experience, he has served on the scientific review committee of the US NIH and was a past board member of the American Association for Endocrinology.
Prof Dr Sunil J. Wimalawansa, Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA Prof. Dr. Wimalawansa is a Professor of Medicine, Director of the CardioMetabolic & Endocrine Institute, and formerly University Professor and Chief of Endocrinology, Metabolism & Nutrition, UMDNJ/Rutgers University. His PhD from the University of London(UK) is in endocrine pathology. Dr. Wimalawansa is globally renowned in endocrinology, with broad expertise in internal medicine, endocrinology, osteoporosis and metabolic bone diseases, chronic kidney disease, nutrition, vitamin D, water and sanitation, and environmental issues. He is a clinician-scientist with more than three decades of experience, a faculty member, medical educator, author, researcher, innovator, administrator, leader, and philanthropist.
He has served on several national and international scientific review committees, including the US NIH, the US Veterans Administration, the Drug Enforcement Agency, and NASA. He is a past board member of the American Association for Endocrinology (AACE/national organization) (2011-2015) and the International Society for Clinical Densitometry (ISCD).
Dr. Wimalawansa has published over 300 peer-reviewed research articles (11,100+ citations; h-Index of 40), 45 reviews and proceedings, 15 book chapters, and 5 medical books. He holds five medical patents in cardiovascular, osteoporosis, and preeclampsia of pregnancy. He is the author of the book, "Vitamin D: Everything You Need to Know" (2012).
He has made several seminal contributions to medicine, medical research, public health, and pharmaceuticals. These include development of novel modes of treating osteoporosis, including combination therapies (1985), nitroglycerine (1987), once-a-week bisphosphonates therapy (1995), and a technique to enhance the efficacy of bisphosphonates (1997); and cost-effective therapies, such as nitric oxide donor treatment (e.g., topical nitroglycerine and oral nitrates; 1987) and vitamin E regimens for treating osteoporosis (1997).
REGISTRATION
This symposium offers complimentary registration. Due to limited seating, early registration is highly encouraged. Register now by clicking the button below:
Register HereNote: Lunch will be served after the lecture.
ORGANIZERS
CONTACT
If you have any inquiries, please do not hesitate to contact the following:
ILSI Southeast Asia Region18 Mohamed Sultan Road #03-01 Singapore 238967
Tel: 65 6352 5220
Email: event@ilsisea.org.sg [post_title] => Vitamin D and Cardiovascular Disease: What is the Latest Science? [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => vit-d-cvd-lecture-2026 [to_ping] => [pinged] => [post_modified] => 2026-02-03 21:18:16 [post_modified_gmt] => 2026-02-04 02:18:16 [post_content_filtered] => [post_parent] => 0 [guid] => https://ilsi.org/?post_type=event&p=52284 [menu_order] => 0 [post_type] => event [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 5 [current_post] => -1 [before_loop] => [in_the_loop] => [post] => WP_Post Object ( [ID] => 52240 [post_author] => 351 [post_date] => 2025-11-27 11:39:58 [post_date_gmt] => 2025-11-27 11:39:58 [post_content] =>
About the event
We are pleased to announce an upcoming expert workshop dedicated to the rapidly evolving landscape of gut-based nutrition and GLP-1 therapies. This 1 ½ days event will bring together scientists, clinicians, and industry leaders to examine the complex interplay between GLP-1 receptor agonists, prebiotics, and the gut-brain axis: an intersection shaping the future of metabolic, cognitive, and mental health.
Workshop Aim
This workshop will bring together leading researchers to examine how GLP-1 therapies and prebiotic strategies influence metabolic regulation, appetite control, cognitive function, and mental well-being through gut-brain communication pathways. Through focused presentations, a World Café-style exchange, and an integrative panel discussion, participants will work collectively to identify key knowledge gaps, refine priority research questions, and define areas where precompetitive collaboration can advance the field. The insights and recommendations that emerge will be synthesized into peer-reviewed proceedings, with Dr. Zoe Kolokotroni (Leeds Beckett University, UK) serving as rapporteur.
Agenda
Day 1
10:00 - Welcome Breakfast & Registration
10:30 - Welcome & Opening Remarks
Session 1 - Gut-Derived Signals in Metabolic Health: From GLP-1 Biology to Prebiotic Modulation
This session examines how prebiotics and gut metabolites, such as short-chain fatty acids, shape metabolic health through the gut-brain axis. Talks will highlight how prebiotic modulation can influence GLP-1 signaling, satiety, and appetite control, with implications for obesity and diabetes management. Overall, the session will showcase emerging strategies that leverage targeted prebiotic interventions to improve metabolic outcomes.
- 10:45 - Prof. Gary Frost, Imperial College London - Understanding the relationship between Prebiotics, gastrointestinal environment and GLP-1 release and physiology
- 11:15 - Prof. Patrice Cani, UCLouvain - Targeting the gut microbiota with prebiotics to modulate endogenous GLP-1: from bench to bedside
- 11:45 - Dr. Harriet Schellekens, University College Cork - Beyond GLP-1 Agonists: Microbiota-Driven Modulation of Satiety and Metabolic Health Across the Lifespan
12:15 - Lunch
Session 2 - From Gut to Brain: Nutritional Modulation of Cognition, Mood, and Eating Behavior
This session explores how nutrition and gut-brain signaling shape cognition, mood, and eating behavior. It will examine both the lived experience of drug treatment and the emerging cognitive and mental health effects of GLP-1-based therapies, moving beyond weight loss to consider broader psychological outcomes.
- 13:20 - Dr. Francesca Cirulli, Prof. Suzanne Dickson (ECNP) - ECNP Network presentation
- 13:30 - Prof. Lora Heisler (University of Aberdeen) -Effect of GLP-1R agonists on consummatory behaviour in mice
- 14:00 - Prof. Kieran Tuohy (University of Leeds) - GLP-RA and the Gut Microbiome - Keeping a Good Thing Going
- 14:30 -Prof. Riccardo De Giorgi, (University of Oxford) - Promises & pitfalls of GLP-1RAs in cognitive and mental disorders: evidence and perspectives
15:00 - Coffee Break
15:30 - World Café Discussion: participants rotate between themed tables to discuss emerging topics, key challenges, and the next steps of the future of metabolic health.
17:00 - Wrap-up and Day 1 Reflections17:15 - Networking Drink
Day 2
9:00 - Welcome to Day 2 & Recap of Day 1
Session 3 - GLP-1 Innovation in Clinical Reality
This session will spotlight how GLP-1-based therapies are reshaping day-to-day clinical practice. The discussion will revolve around real-world use, including benefits, risks, and practical challenges such as access, adherence, and long-term management. The session will offer an up-to-date view of "what's really happening" with GLP-1 in clinics and with patients.
- 9:10 - Prof Giles Yeo (Wolfson College) - University of Cambridge - In a world of GLP1 therapies, have we cured obesity?
- 9:50 - Kelly Dowson (F!S Group) - From Prescription to Reality: What Consumers Really Experience on GLP-1 Medication
10:30 - Coffee break
11:00 - Debrief: Key Points Emerging from the World Café Discussions12:30 - Closing: Summary and Future Outlook
12:45 - End of the workshop
Registration
Register hereFees
- Industry Experts (part of ILSI Europe): free access
- Industry Experts (not part of ILSI Europe): 350€
- Academic Experts (part of ILSI Europe): free access
- Academic Experts (not part of ILSI Europe): 175€
- Public Sector Experts (part of ILSI Europe): free access
- Public Sector Experts (not part of ILSI Europe): 175€
- Students: 75€
Venue
The workshop will take place at the ILSI Europe Office, Avenue E. Mounier 83, Box 6, B-1200 Brussels, Belgium
Find more info on how to reach us here.
Accomodation
Participants are invited to stay at ROXI The Urban Residence Brussels, conveniently located just a 6-minute walk from ILSI Europe (Hippokrateslaan 14, 1932 Zaventem).
The residence offers comfortable, modern accommodation at competitive rates ranging from €77 to €149 per night (plus city tax).
For bookings and enquiries: +32 (0) 2 669 29 70 | brussels@roxi-residence.com | https://roxi-residence.com/.
Organising Commitee
Co-organised by the ILSI Europe Prebiotics Task Force and the Nutrition for the Ageing Brain Symposium Committee
- Georgia Chatonidi - Örebro University
- Lars Christensen - Arla
- Louise Dye - University of Sheffield
- Robert Steinert - DSM
- Clémentine Thabuis - Roquette
- Sandrine Thuret - King's College London
- Maria Tonti - ILSI Europe
- Wim Vandenberghe - University of Antwerp
- David Vauzour - University of East Anglia
- Jessica Van Harsselaar - Beneo
- Elaine Vaughan - Sensus